About Goldencross Pharma Limited
Data last updated: 22 December 2025
Goldencross Pharma Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 21 January 2000, the company has been in operation for over 26 years.
Registered with ROC Mumbai under CIN U24239MH2000PLC123766.
Capital: an authorised share capital of ₹4 Cr and a paid-up capital of ₹4.6 Lakh. Formerly known as Goldencross Pharma Private Limited. It is led by directors including Anisha Naresh Udeshi and Swapn Bhawani Malpani.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹187.87 Cr, a growth of 31% compared to the previous year.
The company has a workforce of approximately 322 employees as per the latest available data. It operates as a subsidiary of Cipla Limited.
As per MCA filings, the company has satisfied charges of ₹91.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cipla.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressTower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Goldencross Pharma Limited
Goldencross Pharma Limited has one previous CIN (Corporate Identification Number): U24239MH2000PTC123766. The current CIN is U24239MH2000PLC123766, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239MH2000PLC123766 | Current |
| U24239MH2000PTC123766 | Previous |
Business Activity of Goldencross Pharma Limited
Goldencross Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Goldencross Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Goldencross Pharma Limited
Goldencross Pharma Limited is audited by Walker Chandiok & Co LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Walker Chandiok & Co LLP | Locked | Locked | Locked |
Complete auditor history for Goldencross Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Goldencross Pharma Limited
Goldencross Pharma Limited is currently managed by 4 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anisha Naresh Udeshi | Director | 08 Jun 2020 | 6 Years 2 Months | Current |
| Swapn Bhawani Malpani | Director | 16 Dec 2024 | 1 Years 7 Months | Current |
| Ujjwal Prakash Shendre | Managing Director | 24 May 2023 | 3 Years 2 Months | Current |
|
Rajendra Kumar Chopra
Also directs:
Meditab Specialities Limited, Cipla Pharma And Life Sciences Limited, Cipla Pharmaceuticals Limited and 3 more
|
Director | 03 Jan 2019 | 7 Years 7 Months | Current |
Financials of Goldencross Pharma Limited FY 2025 filings available
Goldencross Pharma Limited reported revenue of ₹187.87 Cr (up 31.00% YoY) for FY 2025.
Ten-year financial statements for Goldencross Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Goldencross Pharma Limited
Shareholding and ownership data for Goldencross Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Goldencross Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2009 | The Hongkong and Shanghai Banking Corporation Limited | ₹90 Cr | Satisfied |
| 18 Mar 2002 | Credit Lyonnias | ₹75 Lakh | Satisfied |
| 08 Mar 2002 | Credit Lyonnias | ₹75 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Goldencross Pharma Limited
Goldencross Pharma Limited has a workforce of 322 employees as of Mar 30, 2024.
Employee and EPFO history for Goldencross Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Goldencross Pharma Limited
GST registrations and filing compliance for Goldencross Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Goldencross Pharma Limited
Credit ratings, litigation, and regulatory alerts for Goldencross Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Goldencross Pharma Limited
MSME payment history for Goldencross Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Goldencross Pharma Limited
Corporate group structure for Goldencross Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Goldencross Pharma Limited
MCA filings and documents for Goldencross Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Goldencross Pharma Limited
Recent News on Goldencross Pharma Limited
Frequently Asked Questions about Goldencross Pharma Limited
Goldencross Pharma Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 21 January 2000 (26+ years old) and is registered under CIN U24239MH2000PLC123766. The company has 322 employees.
Goldencross Pharma Limited reported revenue of ₹187.87 Cr for FY 2025 (up 31.00% YoY).
The current directors of Goldencross Pharma Limited are:
- Anisha Naresh Udeshi - Director
- Swapn Bhawani Malpani - Director
- Ujjwal Prakash Shendre - Managing Director
- Rajendra Kumar Chopra - Director
The primary industry of Goldencross Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Goldencross Pharma Limited can be reached at the registered office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013, or through the website cipla.com.
The authorised capital is ₹4 Cr, and the paid-up capital is ₹4.6 Lakh.